Antibody-Drug Conjugates (ADCs): A Novel Therapy for Triple-Negative Breast Cancer (TNBC)

被引：4
|
作者：
Gupta, Gaurav [1 ,2 ]
Hussain, Md Sadique [3 ]
Pant, Kumud [4 ,5 ]
Ali, Haider [6 ,7 ]
Thapa, Riya [3 ]
Bhat, Asif Ahmad [3 ]
机构：
[1] Chitkara Univ, Chitkara Coll Pharm, Rajpura, Chandigarh, India
[2] Ajman Univ, Ctr Med & Bioallied Hlth Sci Res, Ajman, U Arab Emirates
[3] Uttaranchal Univ, Uttaranchal Inst Pharmaceut Sci, Dehra Dun 248007, Uttarakhand, India
[4] Graph Era Deemed Univ, Clement Town Dehradun 248002, India
[5] Graph Era Hill Univ, Sch Pharmaceut Sci, Clement Town Dehradun 248002, India
[6] Saveetha Univ, Saveetha Inst Med & Tech Sci, Saveetha Med Coll, Ctr Global Hlth Res, Chennai, India
[7] Kyrgyz State Med Coll, Dept Pharmacol, Bishkek, Kyrgyzstan
来源：
CURRENT CANCER DRUG TARGETS | 2025年 / 25卷 / 02期
关键词：
Antibody-drug conjugates; triple-negative breast cancer; Sacituzumab govitecan; Trop2; antigen; clinical trial;
D O I：
10.2174/0115680096343056240828190900
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：108 / 112
页数：5
相关论文
共 50 条
  • [1] Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs)
    Dri, Arianna
    Arpino, Grazia
    Bianchini, Giampaolo
    Curigliano, Giuseppe
    Danesi, Romano
    De Laurentiis, Michelino
    Del Mastro, Lucia
    Fabi, Alessandra
    Generali, Daniele
    Gennari, Alessandra
    Guarneri, Valentina
    Santini, Daniele
    Simoncini, Edda
    Zamagni, Claudio
    Puglisi, Fabio
    CANCER TREATMENT REVIEWS, 2024, 123
  • [2] Novel antibody-drug conjugates for triple negative breast cancer
    Nagayama, Aiko
    Vidula, Neelima
    Ellisen, Leif
    Bardia, Aditya
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [3] Novel Therapies for Metastatic Triple-Negative Breast Cancer: Spotlight on Immunotherapy and Antibody-Drug Conjugates
    Nagayama, Aiko
    Vidula, Neelima
    Bardia, Aditya
    ONCOLOGY-NEW YORK, 2021, 35 (05): : 249 - 255
  • [4] Antibody-drug conjugates in triple negative breast cancer
    Tray, Nancy
    Adams, Sylvia
    Esteva, Francisco J.
    FUTURE ONCOLOGY, 2018, 14 (25) : 2651 - 2661
  • [5] Antibody-Drug Conjugates in Triple Negative Breast Cancer
    Keskinkilic, Merve
    Sacks, Ruth
    CLINICAL BREAST CANCER, 2024, 24 (03) : 163 - 174
  • [6] Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs) (vol 123, 102672, 2024)
    Dri, Arianna
    Arpino, Grazia
    Bianchini, Giampaolo
    Curigliano, Giuseppe
    Danesi, Romano
    De Laurentiis, Michelino
    Del Mastro, Lucia
    Fabi, Alessandra
    Generali, Daniele
    Gennari, Alessandra
    Guarneri, Valentina
    Santini, Daniele
    Simoncini, Edda
    Zamagni, Claudio
    Puglisi, Fabio
    CANCER TREATMENT REVIEWS, 2024, 125
  • [7] New Biomarkers in a Novel Antibody-Drug Conjugate for Triple-Negative Breast Cancer
    Nagayama, Aiko
    ONCOLOGIST, 2018, 23 : S5 - S5
  • [8] Potential of antibody-drug conjugates (ADCs) for cancer therapy
    Marei, Hany E.
    Cenciarelli, Carlo
    Hasan, Anwarul
    CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [9] Advances in antibody-drug conjugates in the treatment of advanced triple-negative breast cancer: a narrative review
    Jiang, Kuikui
    Wang, Shusen
    TRANSLATIONAL BREAST CANCER RESEARCH, 2025, 6
  • [10] Antibody-drug conjugates targeting RON receptor tyrosine kinase as a novel strategy for treatment of triple-negative breast cancer
    Yao, Hang-Ping
    Suthe, Sreedhar Reddy
    Hudson, Rachel
    Wang, Ming-Hai
    DRUG DISCOVERY TODAY, 2020, 25 (07) : 1160 - 1173
12345